|
Eris Lifesciences Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
21496.39 Cr.
|
P/BV
|
7.76
|
Book Value (Rs.)
|
203.46
|
|
52 Week High/Low (Rs.)
|
1910/1097
|
FV/ML
|
1/1
|
P/E(X)
|
61.10
|
|
Bookclosure
|
13/02/2025
|
EPS (Rs.)
|
25.83
|
Div Yield (%)
|
0.47
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 25.85 | 28.82 | 28.10 | 29.89 | 26.16 |
| Diluted EPS (Rs.) | 25.81 | 28.79 | 28.07 | 29.88 | 26.14 |
| Cash EPS (Rs.) | 50.67 | 42.61 | 36.12 | 34.61 | 29.32 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 209.57 | 190.11 | 163.30 | 140.35 | 116.10 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 209.57 | 190.11 | 163.30 | 140.35 | 116.10 |
| Revenue From Operations / Share (Rs.) | 212.46 | 147.70 | 123.92 | 99.10 | 89.25 |
| PBDIT / Share (Rs.) | 76.03 | 51.36 | 40.29 | 37.60 | 32.35 |
| PBIT / Share (Rs.) | 52.87 | 37.94 | 31.68 | 32.84 | 29.19 |
| PBT / Share (Rs.) | 35.89 | 31.70 | 29.76 | 32.53 | 29.05 |
| Net Profit / Share (Rs.) | 27.50 | 29.19 | 27.51 | 29.85 | 26.16 |
| NP After MI And SOA / Share (Rs.) | 25.83 | 28.82 | 28.10 | 29.88 | 26.16 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 35.78 | 34.77 | 32.51 | 37.93 | 36.24 |
| PBIT Margin (%) | 24.88 | 25.68 | 25.56 | 33.13 | 32.70 |
| PBT Margin (%) | 16.89 | 21.46 | 24.01 | 32.82 | 32.55 |
| Net Profit Margin (%) | 12.94 | 19.76 | 22.20 | 30.12 | 29.30 |
| NP After MI And SOA Margin (%) | 12.15 | 19.50 | 22.67 | 30.14 | 29.30 |
| Return on Networth / Equity (%) | 12.32 | 15.15 | 17.40 | 21.28 | 22.52 |
| Return on Capital Employeed (%) | 12.74 | 11.42 | 13.36 | 21.53 | 23.76 |
| Return On Assets (%) | 5.00 | 5.56 | 10.42 | 17.87 | 19.35 |
| Long Term Debt / Equity (X) | 0.60 | 0.25 | 0.29 | 0.02 | 0.00 |
| Total Debt / Equity (X) | 0.84 | 1.06 | 0.37 | 0.02 | 0.00 |
| Asset Turnover Ratio (%) | 0.41 | 0.37 | 0.52 | 0.61 | 0.67 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 0.88 | 0.90 | 1.73 | 3.14 | 2.80 |
| Quick Ratio (X) | 0.64 | 0.83 | 1.43 | 2.55 | 2.23 |
| Inventory Turnover Ratio (X) | 11.05 | 1.11 | 1.26 | 1.31 | 1.48 |
| Dividend Payout Ratio (NP) (%) | 28.43 | 0.00 | 26.15 | 20.10 | 21.02 |
| Dividend Payout Ratio (CP) (%) | 14.99 | 0.00 | 20.01 | 17.34 | 18.75 |
| Earning Retention Ratio (%) | 71.57 | 0.00 | 73.85 | 79.90 | 78.98 |
| Cash Earning Retention Ratio (%) | 85.01 | 0.00 | 79.99 | 82.66 | 81.25 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 4.48 | 8.24 | 20.94 | 123.26 | 243.78 |
| Interest Coverage Ratio (Post Tax) (%) | 2.62 | 5.68 | 15.30 | 98.87 | 198.08 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 21908.96 | 13413.39 | 8575.56 | 9359.51 | 8168.96 |
| EV / Net Operating Revenue (X) | 7.57 | 6.68 | 5.09 | 6.95 | 6.74 |
| EV / EBITDA (X) | 21.16 | 19.20 | 15.65 | 18.31 | 18.60 |
| MarketCap / Net Operating Revenue (X) | 6.67 | 5.70 | 4.62 | 6.95 | 6.77 |
| Retention Ratios (%) | 71.56 | 0.00 | 73.84 | 79.89 | 78.97 |
| Price / BV (X) | 6.76 | 4.42 | 3.54 | 4.91 | 5.21 |
| Price / Net Operating Revenue (X) | 6.67 | 5.70 | 4.62 | 6.95 | 6.77 |
| EarningsYield | 0.01 | 0.03 | 0.04 | 0.04 | 0.04 |
